103 related articles for article (PubMed ID: 3572026)
1. The cytotoxicity of cysteinylcatechols and related compounds to human melanoma cells in vitro.
Yamada I; Seki S; Matsubara O; Ito S; Suzuki S; Kasuga T
J Invest Dermatol; 1987 May; 88(5):538-40. PubMed ID: 3572026
[TBL] [Abstract][Full Text] [Related]
2. The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its n-acetyl derivative.
Miura T; Jimbow K; Ito S
Int J Cancer; 1990 Nov; 46(5):931-4. PubMed ID: 2121652
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds.
Ito S; Inoue S; Yamamoto Y; Fujita K
J Med Chem; 1981 Jun; 24(6):673-7. PubMed ID: 6788955
[TBL] [Abstract][Full Text] [Related]
4. Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol.
Inoue S; Hasegawa K; Ito S; Ozeki H; Solano F; Jiménez-Cervantes C; Wakamatsu K; Fujita K
Cancer Res; 1995 Jun; 55(12):2603-7. PubMed ID: 7780975
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxicity of endogenous cysteinylcatechols.
Montine TJ; Picklo MJ; Amarnath V; Whetsell WO; Graham DG
Exp Neurol; 1997 Nov; 148(1):26-33. PubMed ID: 9398447
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes.
Ito S; Kato T; Ishikawa K; Kasuga T; Jimbow K
Biochem Pharmacol; 1987 Jun; 36(12):2007-11. PubMed ID: 3109434
[TBL] [Abstract][Full Text] [Related]
7. [Utilization of melanin precursors for experimental chemotherapy of malignant melanoma].
Jimbow K; Miura S; Ito Y; Kasuga T; Ito S
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2125-32. PubMed ID: 6435538
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
Gili A; Thomas PD; Ota M; Jimbow K
Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
[TBL] [Abstract][Full Text] [Related]
9. Potency, selectivity and cell cycle dependence of catechols in human tumour cells in vitro.
Kable EP; Parsons PG
Biochem Pharmacol; 1988 May; 37(9):1711-5. PubMed ID: 3132176
[TBL] [Abstract][Full Text] [Related]
10. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
Jimbow K
Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
[TBL] [Abstract][Full Text] [Related]
11. Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs.
Thomas PD; Kishi H; Cao H; Ota M; Yamashita T; Singh S; Jimbow K
J Invest Dermatol; 1999 Dec; 113(6):928-34. PubMed ID: 10594732
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol.
Prezioso JA; Wang N; Bloomer WD
Cancer Chemother Pharmacol; 1992; 30(5):394-400. PubMed ID: 1505078
[TBL] [Abstract][Full Text] [Related]
13. Effects of tyrosinase activity on the cytotoxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol in melanoma cells.
Prezioso JA; Epperly MW; Wang N; Bloomer WD
Cancer Lett; 1992 Mar; 63(1):73-9. PubMed ID: 1555210
[TBL] [Abstract][Full Text] [Related]
14. Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells.
Kable EP; Parsons PG
Cancer Chemother Pharmacol; 1989; 23(1):1-7. PubMed ID: 2909284
[TBL] [
